Fengjie Liu
- Toxicology top 10%
-
- Nanoparticle-Based Drug Delivery 4
-
- Flavonoids in Medical Research 4
-
- Natural product bioactivities and synthesis 4
- Phytochemical Studies and Bioactivities 4
- Metabolomics and Mass Spectrometry Studies 3
-
- Cancer, Stress, Anesthesia, and Immune Response 3
-
- MicroRNA in disease regulation 3
-
- Nanoplatforms for cancer theranostics 3
- Journals
- The Journal of Immunology (1 paper)Journal of Chromatography A (1 paper)Cellular and Molecular Life Sciences (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Fengjie Liu
36 papers receiving 390 citations
Peers
Comparison fields: 5 of 78
- Toxicology 20
- Biomaterials 76
- Complementary and alternative medicine 34
- Pharmacology 35
- Molecular Medicine 17
Countries citing papers authored by Fengjie Liu
This map shows the geographic impact of Fengjie Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjie Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjie Liu more than expected).
Fields of papers citing papers by Fengjie Liu
This network shows the impact of papers produced by Fengjie Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjie Liu. The network helps show where Fengjie Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fengjie Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 37 | |
| 14 | 2021 | 2 | |
| 15 | 2021 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2020 | 4 | |
| 18 | Cytochrome P450-mediated detoxification involves in phosphine resistance mechanism in the red flour beetle of Tribolium castaneum | 2015 | 4 |
| 19 | 2015 | 7 | |
| 20 | An epidemiological survey on human hydatidosis in southern Qinghai Plateau. | 2000 | 2 |
About Fengjie Liu
Fengjie Liu is a scholar working on Cancer Research, Complementary and alternative medicine and Molecular Medicine, having authored 40 papers that have together received 396 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Phytochemical Studies and Bioactivities (4 papers), Flavonoids in Medical Research (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), MicroRNA in disease regulation (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Toxicology (20 citations), Biomaterials (76 citations) and Complementary and alternative medicine (34 citations). Fengjie Liu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yu Cai, Tiange Cai, Meng Lan, Tengteng Zou, Hui‐Jun Li, Yan Jiang, Ravit Arav‐Boger, Sujayita Roy, Wenping Lü and Lihong Li. Their work appears in journals such as The Journal of Immunology, Journal of Chromatography A and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.